Resyca
Resyca, a joint venture between Bespak and Medspray, develops next-generation soft mist inhalers, including prefilled syringes inhalers, for the delivery of both small and large molecules, and designed to optimise lung deposition whilst minimising oropharyngeal deposition.
Associated Companies
BespakResyca develops next-generation soft mist inhalers for the delivery of both small and large molecules, and designed to optimise lung deposition whilst minimising oropharyngeal deposition. Its soft mist inhaler platform consists of both prefilled syringes inhalers and clinical trial devices that can be filled on the spot, speeding up clinical investigations.
Resyca is a joint venture between Bespak and Medspray.
Articles by Resyca
